RSH 0.00% 2.5¢ respiri limited

Ann: CEO Operational Review, page-10

  1. 1,973 Posts.
    lightbulb Created with Sketch. 82

    I think you should read up on what it is like to live with asthma. Then you will understand the need for Respiri management tool which will use a smartphone to record datA on a daily basis using a hand held device.which monitors wheeze.

    Resap is a tool that can diagnose what type of respiratory disease the person has when they present with a problem. They will cough into smart phone and a diagnosis is made. Is it pneumonia or is it a myriad of other problems including asthma? If asthma then they will require the Respri asthma management tool which will help them to manage their condition and hopefully reduce severe attacks.

    Therefore imo they are not competitors but will be complementary.

    Even if they were competing why try and make an issue here? Competition is healthy and is a natural part of business today.
    Last edited by birdchirp: 07/08/18
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
0.000(0.00%)
Mkt cap ! $34.68M
Open High Low Value Volume
2.7¢ 2.7¢ 2.5¢ $1.98K 73.34K

Buyers (Bids)

No. Vol. Price($)
3 799980 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 5000 1
View Market Depth
Last trade - 11.21am 22/08/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.